Vertex Pharmaceuticals SG&A Expense (TTM) Analysis

Vertex Pharmaceuticals Inc (VRTX)

445.21 +4.57 (+1.04%) USD | NASDAQ | May 17, 16:00

445.28 +0.08 (+0.02%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1992. Upgrade now.

Date	Value
March 31, 2024	1.238B
December 31, 2023	1.137B
September 30, 2023	1.035B
June 30, 2023	1.018B
March 31, 2023	970.60M
December 31, 2022	944.70M
September 30, 2022	932.50M
June 30, 2022	883.90M
March 31, 2022	863.20M
December 31, 2021	840.10M
September 30, 2021	796.79M
June 30, 2021	783.14M
March 31, 2021	780.34M
December 31, 2020	770.50M
September 30, 2020	753.89M
June 30, 2020	729.02M
March 31, 2020	693.71M
December 31, 2019	658.50M
September 30, 2019	616.43M
June 30, 2019	594.05M
March 31, 2019	574.85M
December 31, 2018	557.62M
September 30, 2018	539.20M
June 30, 2018	522.62M
March 31, 2018	512.56M

Date	Value
December 31, 2017	496.08M
September 30, 2017	471.19M
June 30, 2017	456.54M
March 31, 2017	440.94M
December 31, 2016	432.83M
September 30, 2016	419.47M
June 30, 2016	413.19M
March 31, 2016	395.93M
December 31, 2015	376.58M
September 30, 2015	358.55M
June 30, 2015	334.00M
March 31, 2015	317.06M
December 31, 2014	305.41M
September 30, 2014	299.94M
June 30, 2014	311.14M
March 31, 2014	340.22M
December 31, 2013	358.88M
September 30, 2013	392.16M
June 30, 2013	403.42M
March 31, 2013	414.41M
December 31, 2012	432.68M
September 30, 2012	448.22M
June 30, 2012	461.20M
March 31, 2012	440.34M
December 31, 2011	400.72M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

594.05M

Minimum

Jun 2019

1.238B

Maximum

Mar 2024

851.95M

Average

818.44M

Median

SG&A Expense (TTM) Benchmarks